A 2012 study demonstrated that roughly one-third of antimalarial medications in Southeast Asia and Sub-Saharan Africa failed chemical analysis, packaging analysis, or were falsified.
2012年的研究显示，东南亚和撒哈拉以南非洲大约三分之一的抗疟药为化学成分或包装不合格的伪劣药品。